ArticlePDF AvailableLiterature Review


Thiamin is a hydrosoluble vitamin that plays a role in several biological processes, mainly in glucose metabolism. There are several risk factors for developing thiamin deficiency, such as malnutrition, refeeding syndrome, gastrointestinal surgery, and alcoholism. Recently, the role of thiamin in critically ill patients has gained prominence, and the prevalence of thiamin deficiency was found to be increased in patients with severe burns, major surgery, septic shock, end‐stage renal disease, and heart failure. In adults, thiamin deficiency presents as encephalopathy, dry beriberi (with neurological signs and symptoms), or wet beriberi (with cardiovascular signs and symptoms). Thiamin deficiency can be diagnosed clinically, and all clinicians should be aware of this disease, especially in patients with risk factors for thiamin deficiency. Thiamin supplementation should be started as early as possible in patients suspected to have thiamin deficiency. Treatment is safe, inexpensive, simple, and life‐saving. Diagnosis is confirmed on a positive response to treatment.
Nutrition in Clinical Practice
Volume 00 Number 0
xxxx 2019 1–7
C2019 American Society for
Parenteral and Enteral Nutrition
DOI: 10.1002/ncp.10234
Role of Thiamin in Health and Disease
Bertha F. Polegato, MD, PhD ; Amanda G. Pereira, MS; Paula S. Azevedo, MD,
PhD; Nara A. Costa, PhD; Leonardo A. M. Zornoff, MD, PhD;
Sergio A. R. Paiva, MD, PhD; and Marcos F. Minicucci, MD, PhD
Thiamin is a hydrosoluble vitamin that plays a role in several biological processes, mainly in glucose metabolism. There are several
risk factors for developing thiamin deciency, such as malnutrition, refeeding syndrome, gastrointestinal surgery, and alcoholism.
Recently, the role of thiamin in critically ill patients has gained prominence, and the prevalence of thiamin deciency was found to
be increased in patients with severe burns, major surgery, septic shock, end-stage renal disease, and heart failure. In adults, thiamin
deciency presents as encephalopathy, dry beriberi (with neurological signs and symptoms), or wet beriberi (with cardiovascular
signs and symptoms). Thiamin deciency can be diagnosed clinically, and all clinicians should be aware of this disease, especially
in patients with risk factors for thiamin deciency. Thiamin supplementation should be started as early as possible in patients
suspected to have thiamin deciency. Treatment is safe, inexpensive, simple, and life-saving. Diagnosis is conrmed on a positive
response to treatment. (Nutr Clin Pract. 2019;00:1–7)
beriberi; Korsakoff syndrome; thiamin; thiamin deciency; Wernicke encephalopathy
Thiamin: Function and Sources
Thiamin, also called vitamin B1, plays a role in several
biological processes and is therefore an important vitamin
for the body. The deciency of this vitamin is a critical
issue because it is still underdiagnosed and is associated
with high morbidity and mortality. Mortality rates close
to 20% have been observed in untreated or inadequately
treated patients, and up to 85% of survivors can develop
an irreversible neurological condition.1,2 Although access
to food is easier nowadays, micronutrient deciency is
widespread in industrialized and developing nations.
One of thiamin’s primary functions is acting as a
cofactor of enzymes involved in generating energy and
in the metabolism of glucose, such as the pyruvate de-
hydrogenase complex, transketolase, and α-ketoglutarate
dehydrogenase.3,4 Consequently, thiamin deciency leads
to decreased activity of these enzymes, reduction of pyru-
vate oxidation, and lactate accumulation in the brain and
blood. All of these features are accompanied by decreased
production of adenosine triphosphate. Lactate accumula-
tion leads to lactic acidosis, and the decrease in pH of
the brain can contribute to the onset of the neurological
manifestations that accompany thiamin deciency.5,6 In
addition, a reduction in enzyme activity leads to a decrease
in the synthesis of neurotransmitters, such as acetylcholine
and γ-aminobutyric acid, which may further worsen brain
function (Figure 1).5,7,8
Because our bodies do not synthesize thiamin, our
thiamin needs must be met through diet. There are several
dietary sources of thiamin: meat (especially lean cuts of
pork), yeasts, grains, cereals, and other products of plant
origin.9,10 Thiamin is present in plant products, almost in
its entirety, in phosphorylated form as thiamin diphosphate
ester (also called thiamin pyrophosphate), which is the
active form of the vitamin.11,12 Among vegetables, the main
sources of thiamin are legumes, including peas, lentils, and
potatoes. Despite this, the prolonged cooking of vegetables,
mainly in water, can considerably diminish the availability
of thiamin because it is thermosensitive and hydrosoluble.7
Diets based on polished rice are a risk factor for thiamin
deciency because it is a poor source of thiamin.13
Some factors interfere signicantly with thiamin absorp-
tion, such as the type of food processing, alcohol intake,
From the Internal Medicine Department, Medical School, S˜
ao Paulo
State University (Unesp), Botucatu, S˜
ao Paulo, Brazil.
Financial disclosure: None declared.
Conicts of interest: None declared.
This article originally appeared online on xxxx 0, 2018.
Corresponding Author:
Bertha F. Polegato, Internal Medicine Department, Botucatu Medical
School, S˜
ao Paulo State University (Unesp), Av. Prof. M´
ario Rubens
aes Montenegro, s/n, UNESP – Campus de Botucatu, S ˜
Paulo 18618687, Brazil.
2Nutrition in Clinical Practice 00(0)
Figure 1. (A) Thiamin functions. Thiamin serves as a cofactor for enzymatic activity of transketolase, α-ketoglutarate
dehydrogenase, and pyruvate dehydrogenase complex. Thiamin participates in glucose metabolism, energy generation, and
synthesis of nucleic acids. In thiamin deciency status (B), activity of these enzymes is decreased. Consequently, there is a
reduction of pyruvate oxidation and lactate accumulation and a decrease in pH and acidosis (in the brain and blood). Decreased
pyruvate dehydrogenase complex and α-ketoglutarate dehydrogenase activity interfere with Krebs cycle and impair ATP
generation. Additionally, myelin sheaths are damaged, leading to neurological decits. ATP, adenosine triphosphate; acetyl CoA,
acetyl coenzyme A; I, complex I of mitochondrial respiratory chain; II, complex II of mitochondrial respiratory chain; III,
complex III of mitochondrial respiratory chain; IV, complex IV of mitochondrial respiratory chain; V, ATP synthase.
protein and folate nutrition level, and the presence of
antithiaminic factors in the diet.14-17 Intake of raw foods
with high thiaminase content (such as crustaceans, sprouts,
microorganisms, and some sh) can contribute or even
be the direct cause of thiamin deciency.16,18 Thiaminase
is also thermolabile, and the act of cooking these foods
considerably reduces the risk of thiamin deciency.9,15 In
addition, ingestion of beverages such as coffee, tea, and
other beverages rich in tannins also contributes to thiamin
deciency.9,19 On the other hand, ingestion of juices from
citrus fruits increases the bioavailability of thiamin because
of their citric acid and ascorbic acid content.20,21
Thiamin absorption from the diet occurs throughout the
small intestine, especially in the jejunum, depending on the
pH of the medium.11,22 The absorption is severely decreased
in the presence of alkaline pH, and it occurs in passive
and active forms. Passive absorption occurs when there are
large amounts of thiamin in the intestinal lumen, whereas
Polegato et al 3
active absorption occurs when thiamin is present in small
amounts.5,7 Alcoholism is one of the most important factors
leading to decreased absorption of thiamin because alcohol
inhibits the active transport of the vitamin by up to 50%,
even in patients with good nutrition status.7,23
The daily needs of thiamin vary according to sex and age
group; for adults, the recommendation is about 1.1–1.2 mg
per day and 1.4 mg per day for pregnant women.7,22 For
comparison, 100 g of pork provides about 1 mg of thiamin,
1 cup of cereals provides around 2 mg, and 1 cup of cooked
peas provides about 0.8 mg of thiamin.9Ingesting quantities
much larger than these recommended ones, whether from
dietary sources or oral supplementation, usually does not
cause any side effects.11
Risk Factors for Thiamin Deciency
All patients with malnutrition or nutrition risk are potential
candidates for thiamin deciency, regardless of the etiology
of malnutrition. In addition, malnourished patients or
patients in prolonged fasting who will be articially fed
may develop refeeding syndrome.24,25 During refeeding, the
increased supply of glucose leads to increased secretion
of insulin and decreased secretion of glucagon, thereby
stimulating the synthesis of glycogen, fats, and proteins,
with a consequent inux of phosphate, potassium, and mag-
nesium into the intracellular medium, whereas serum con-
centrations are markedly diminished.26,27 In addition, with
glucose now available because of refeeding, the metabolism
increases with consequent depletion of thiamin, which
serves as a cofactor of enzymatic reactions.28,29
Causes of thiamin deciency include the use of the
diuretic furosemide, the presence of chronic kidney disease
on hemodialysis, diabetes mellitus with increased urinary
excretion of thiamin, malignant neoplasms, acquired im-
munodeciency syndrome, hyperemesis gravidarum, and
diseases and surgeries of the gastrointestinal tract, including
bariatric surgery.1,7,9,30 Bariatric surgeries increase the risk
of thiamin deciency through several mechanisms, includ-
ing lower vitamin intake, higher prevalence of postoperative
vomiting, and impaired absorption, mainly in patients who
have undergone Roux-en-Y gastric bypass surgery. In these
patients, the bypass of the small intestine, the preferred
location for thiamin absorption, and bacterial overgrowth
are important causes of thiamin deciency.31-33 In addition,
obesity alone can increase risk of thiamin deciency. In
general, these patients consume a diet poor in vegetables
and rich in simple sugars and processed foods, which is a
low source of thiamin.9,19
The main and most important risk factor for thiamin
deciency is alcoholism.19,22 There are several mechanisms
associated with alcohol intake and thiamin deciency. One
is the decrease in thiamin absorption in the small intestine,
which is already mentioned above. Another reason is that
alcohol intake causes decreased caloric intake from sources
other than alcohol and thus reduces the supply of thiamin
from the diet.34,35 In addition, liver cirrhosis, a complication
of chronic alcoholism, also leads to a decreased supply
of thiamin to the liver.7Postmortem studies have shown
that the prevalence of Wernicke’s encephalopathy, one of
the clinical features of thiamin deciency, among patients
with alcoholism varies from 12.5% to 35%, whereas the
prevalence of this encephalopathy in the general population
is 1.5%.7,36-39
Recently, the role of thiamin in critically ill patients has
gained much attention. It is known that patients with septic
shock, severe burns, recent cardiac surgery, and renal failure
present with lower serum thiamin levels.40,41 In addition,
thiamin deciency in patients with septic shock admitted to
the intensive care unit can reach up to 70%.42 It is not known
exactly when, how, or if thiamin should be replaced for
critically ill patients in the absence of clinical deciency, but
new evidence is emerging. In patients with septic shock, the
administration of thiamin in the subgroup of patients with
a deciency of the vitamin led to a reduction in mortality.43
However, thiamin replacement in patients who underwent
myocardial revascularization surgery did not change clinical
outcomes such as postoperative serum lactate concentration
or the number of hospitalization days.44 Box 1 summarizes
the risk factors for thiamin deciency.
Box 1. Risk Factors for Thiamin Deciency
Refeeding syndrome
Bariatric surgery
Other gastrointestinal tract surgery
Critical illness
Diabetes mellitus
Hyperemesis gravidarum
Chronic kidney disease on hemodialysis
Polished rice-based diet
Furosemide intake
Acquired immunodeciency syndrome
Clinical Manifestations
The 2 classical clinical forms of thiamin deciency are
Wernicke-Korsakoff syndrome45 and beriberi; the latter can
be classied as wet beriberi, dry beriberi,46 and infantile
beriberi. This article does not include discussion on infantile
beriberi. Box 2 shows the main clinical manifestations of
thiamin deciency.
4Nutrition in Clinical Practice 00(0)
Box 2. Clinical Manifestation of Thiamin
Wernicke-Korsakoff syndrome
Mental confusion1
Ocular signs such as nystagmus and ophthalmoplegia1
Loss of short-term memory2
Temporospatial disorientation2
Mood changes2
Dry beriberi
Weakness of the lower limbs
Peripheral symmetric sensory-motor polyneuropathy
Wet beriberi
Tac hy cardi a
Increased cardiac chambers
Shoshin beriberi
Heart failure plus:
Decreased cardiac output
Increased lactate levels
1Classical triad of Wernicke encephalopathy.
2Korsakoff syndrome symptoms.
Wernicke-Korsakoff syndrome presents 2 clinical foci:
Wernicke’s encephalopathy and Korsakoff’s syndrome, of-
ten referred to in conjunction as Wernicke-Korsakoff
syndrome.47 Wernicke’s encephalopathy manifests as ataxia,
mental confusion, and abnormal ocular signs such as
nystagmus and ophthalmoplegia.48,49 However, this triad
is present in only a small portion of patients, which can
hinder the diagnosis.1,50 The presence of only 1 of the
events described in the classic triad and of at least 1 risk
factor for deciency should raise diagnostic suspicion.2
Together with the classical clinical condition, the presence
of other neurological symptoms such as irritability, seizures,
paresthesias, papilledema, and even coma is not rare.1
Because thiamin deciency is a disease whose diagnosis is
based solely on clinical ndings, in almost all cases, it is
essential to rule out other diagnoses. Imaging studies are
therefore crucial in such cases. Computed tomography scans
of the brain are usually normal, but magnetic resonance
imaging, although not very sensitive, provides very specic
ndings of the disease, such as bilateral and symmetrical T2
signal increase in the thalamus, hypothalamus, oor of the
fourth ventricle, mamillary bodies, and the midline of the
Wernicke’s encephalopathy occurs or is even accompa-
nied by Korsakoff’s syndrome in 80% of patients, mainly
when thiamin deciency is not treated properly.1Although
rare, Korsakoff’s syndrome might not be accompanied by
Wernicke’s encephalopathy. It is characterized by chronic,
persistent, and severe loss of short-term memory, and
confabulation may be present, especially at the beginning
of the clinical picture. Temporospatial disorientation and
mood changes can also be present.51 In general, the motor
functions are preserved.
Korsakoff’s syndrome is a differential diagnosis of
patients with dementia. However, the diagnosis of this
syndrome is often neglected, leading to treatment delay and
permanent decits. Despite the lack of uniform response,
the early identication and treatment of Korsakoff’s
syndrome can change the outcomes of these patients.1
Regarding beriberi, the dry form is characterized by
peripheral polyneuropathy, which is predominantly distal,
related to sensory-motor, and symmetrical.10,33 The onset
of the condition is usually not acute, and patients typically
mention weakness of the lower limbs. Some cases may
have a quicker onset and mimic other paresthesias, such as
e syndrome.52,53 Most patients show a good
response to thiamin replacement.54
Wet beriberi presents as congestive high-output heart
failure.55 The exact mechanisms by which thiamin deciency
leads to heart failure are not yet completely understood, but
it is believed that the energy decit in the myocardium that is
due to the decreased enzyme activity may play an important
role.56,57 In addition, thiamin deciency causes peripheral
vasodilation, decreased organ perfusion, and subsequent
retention of sodium and water, which may generate a
hypervolemic state and a consequent increase in peripheral
venous pressure and edema.55
The diagnosis of wet beriberi is made for patients who
meet all of the following criteria: 1) increased cardiac
chambers in echocardiography study, 2) edema, 3) high
central venous pressure, 4) peripheral polyneuropathy, 5)
absence of another cause of heart failure, 6) history of con-
sumption of a thiamin-decient diet for at least 3 months,
and 7) improved symptoms and decreased cardiac chambers
in response to thiamin supplementation. In addition, pa-
tients may show tachycardia, increased serum troponin, and
acidosis.58-60 In some cases, heart failure may be followed
by decreased cardiac output and shock. Hemodynamic
deterioration is accompanied by markedly increased lactate
levels and acidosis.59,61 This form of wet beriberi is the
most severe and is known as Shoshin beriberi (from the
Japa nese sho =acute, shin =heart). These patients need
to be diagnosed quickly because the disease could progress
to death in a short time.62,63 In these patients, atypical
Polegato et al 5
clinical presentations are observed, including pulmonary
hypertension and right ventricular failure.64
The complementary examinations conducted to evaluate
patients with suspected wet beriberi are the same as those
used to investigate other diseases that cause heart failure, in-
cluding blood biochemical analysis, chest x-ray, electrocar-
diogram, and echocardiography.65 These examinations are
useful for the identication of cardiac hypertrophy caused
by beriberi and the exclusion of other causes of heart failure.
The various clinical forms of thiamin deciency can
occur in isolation or in a concomitant way in the same
patient,60 depending on the cause of deciency, age of the
patient, presence of other comorbidities, genetic suscep-
tibility, degree of deciency, and speed of onset. Asians
tend to manifest thiamin deciency most often as wet
beriberi, whereas Europeans tend to develop dry beriberi
and Wernicke’s encephalopathy.1In addition, severe thiamin
deciency with rapid onset usually leads to Wernicke’s
encephalopathy, whereas mild to moderate deciency with
slow and prolonged onset tends to evolve into peripheral
The concentration of thiamin in the blood is not an appro-
priate parameter to evaluate the body supply of thiamin.10
The best approach to determine the thiamin nutrition status
of an individual would be through indirect methods, such
as the evaluation of transketolase activity in erythrocytes
or the determination of concentration of thiamin diphos-
phate ester in erythrocytes through high-performance liquid
chromatography.7,66 However, these methods are expensive
and rarely available in clinical practice, and the diagnosis
is usually made based on the clinical condition of the
patient and satisfactory response to the therapeutic test.2
Therefore, it is very important for the clinicians to keep a
high suspicion and to be aware of the signs and symptoms
of thiamin deciency, especially in patients with risk factors
for deciency.
Misdiagnosis can often occur in the emergency room,
where the patient needs to be cared for quickly and the
clinical history taken, in general, is quite concise. Some
signs and symptoms of thiamin deciency are sometimes
confused with those of the patient’s underlying disease,
where the decits observed can be wrongly attributed, for
example, to alcoholism or to heart failure itself.60
Treatment regimens reported in the literature vary widely
and depend on the cause of thiamin deciency and the
clinical manifestations of the patients. For the treatment of
Wernicke-Korsakoff syndrome in patients with alcoholism,
thiamin deciency should be treated with 500 to 1500 mg
per day, 2 or 3 doses, through intramuscular injection or
intravenous route for 5 days. After this initial period, the
recommendation is an oral dose of 300 mg per day for
1–2 weeks, followed by 100 mg daily for maintenance.2,67
Some authors recommend that thiamin replacement with
high doses intravenously should be maintained for longer
periods of up to 2 months.50 However, most recommen-
dations suggest initial parenteral replacement periods of
up to 1 week or until symptoms improve. After starting
replacement, the ocular manifestations and ataxia usually
regress within hours or days, but mental confusion can take
2 or 3 weeks to improve.1
It is important that the initial thiamin replacement be
parenteral because these patients have a signicant decit of
thiamin absorption. In addition, patients with alcoholism,
even without clinical deciency, should always receive thi-
amin before any replacement of glucose because the supply
of glucose can increase the need for thiamin in a patient who
often has a small reserve of the vitamin and thus precipitates
the emergence of exuberant clinical deciency.67,68
Patients without alcoholism who have a diagnosis of
Wernicke-Korsakoff syndrome require lower doses of thi-
amin than patients with alcoholism, with doses of 100–
300 mg per day being enough to obtain clinical response,
but there is also need for parenteral replacement in the
early days.60
Treatment of wet beriberi includes thiamin supplemen-
tation accompanied by hemodynamic support. The rec-
ommended dose used for the treatment of wet beriberi is
usually small and may be provided orally. Overall, doses of
100–300 mg per day are enough to improve symptoms.7In
Shoshin beriberi, when patients are severely ill, parenteral
administration may be recommended for initial treatment,
followed by oral administration.61,64 Some authors recom-
mend a high dose of thiamin,69 but most suggest 100–
300 mg per day in these cases. Thiamin replacement should
be maintained for an extended period and until the risk
factor for thiamin deciency is removed.
Thiamin supplementation is also indicated for the pre-
vention and treatment of refeeding syndrome, with the
recommended oral dose of 100–300 mg per day. Thiamin
replacement must be started concomitantly to the refeed-
ing of patients at risk of developing the syndrome and
maintained for 10 days after refeeding begins.7,28
Oral ingestion of quantities larger than those recom-
mended usually does not cause any side effects. However,
the parenteral administration of thiamin for therapeutic
purposes can cause severe complications such as anaphy-
laxis and cardiopulmonary arrest, although the frequency
of these events is rare.1,7 Parenteral thiamin must be diluted
in 100 mL of saline solution and infused over 30 minutes
to decrease the risk of side effects. Ideally, every patient
receiving thiamin intravenously should be monitored by a
healthcare team with access to resuscitation facilities during
the infusion of medication; however, the absence of such
6Nutrition in Clinical Practice 00(0)
a team should not delay the administration of the vitamin
because of the high potential of developing disability in the
case of severe deciency.
Thiamin replacement in other patient groups, such as in
critically ill patients with an absence of diagnosed deciency,
is still controversial. Although some authors recommend
prophylactic supplementation in these situations, scientic
evidence for this practice has not been established.57
The exact prevalence of thiamin deciency is unknown.
However, autopsy studies have reported higher prevalence
of thiamin deciency than clinical studies, which suggests
that the disease is underdiagnosed.1More risk factors
for thiamin deciency have now been recognized, and the
disease has been diagnosed in patients without classical
risk factors, such as in critically ill patients.40 In addition,
patients may have a subclinical thiamin deciency, and most
of these cases are not currently treated.
It is essential to prioritize research on thiamin deciency.
It is also important to identify easier methods to diagnose
thiamin deciency or to improve those already available in
order to simplify their methods, reduce costs, and increase
their availability. Although there are not efcient ways
to make the diagnosis, clinicians must maintain a high
suspicion of the disease and treat patients promptly if a
diagnosis is suspected. The treatment is inexpensive, simple,
and life-saving.
Statement of Authorship
L. A. M. Zornoff, S. A. R. Paiva, and M. F. Minicucci
equally contributed to the conception and design of the
research; P. S. Azevedo contributed to the design of the
research; B. F. Polegato, A. G. Pereira, and N. A. Costa
contributed to the acquisition and analysis of the data;
Azevedo contributed to the interpretation of the data; and
B. F. Polegato, A. G. Pereira, and N. A. Costa drafted the
manuscript. All authors critically revised the manuscript,
agree to be fully accountable for ensuring the integrity and
accuracy of the work, and read and approved the nal
1. Sechi G, Serra A. Wernicke’s encephalopathy: new clinical settings
and recent advances in diagnosis and management. Lancet Neurol.
2. Latt N, Dore G. Thiamine in the treatment of Wernicke encephalopa-
thy in patients with alcohol use disorders. Intern Med J. 2014;44(9):
3. Wooley JA. Characteristics of thiamin and its relevance to the manage-
ment of heart failure. Nutr Clin Pract. 2008;23(5):487-493.
4. Sica DA. Loop diuretic therapy, thiamine balance, and heart failure.
Congest Heart Fail. 2007;13(4):244-247.
5. Manzetti S, Zhang J, van der Spoel D. Thiamin function, metabolism,
uptake, and transport. Biochemistry. 2014;53(5):821-835.
6. Abdou E, Hazell AS. Thiamine deciency: an update of pathophysi-
ologic mechanisms and future therapeutic considerations. Neurochem
Res. 2015;40(2):353-361.
7. Frank LL. Thiamin in clinical practice. JPEN J Parenter Enteral Nutr.
8. Fernandes LMP, Bezerra FR, Monteiro MC, et al. Thiamine de-
ciency, oxidative metabolic pathways and ethanol-induced neurotox-
icity: how poor nutrition contributes to the alcoholic syndrome, as
Marchiafava-Bignami disease. Eur J Clin Nutr. 2017;71(5):580-586.
9. Kerns JC, Arundel C, Chawla LS. Thiamin deciency in people with
obesity. Adv Nutr. 2015;6(2):147-153.
10. WHO | Thiamine deciency and its prevention and control in ma-
jor emergencies. WHO. Available at:
publications/emergencies/WHO_NHD_99.13/en/. Accessed April 12,
11. Brown G. Defects of thiamine transport and metabolism. J Inherit
Metab Dis. 2014;37(4):577-585.
12. Amrein K, Oudemans-van Straaten HM, Berger MM. Vitamin therapy
in critically ill patients: focus on thiamine, vitamin C, and vitamin D.
Intensive Care Med. 2018;44(11):1940-1944.
13. Dong W, Thomas N, Ronald PC, Goyer A. Overexpression of thiamin
biosynthesis genes in rice increases leaf and unpolished grain thiamin
content but not resistance to xanthomonas oryzae pv. oryzae. Front
Plant Sci. 2016;7:1-11.
14. Said HM. Intestinal absorption of water-soluble vitamins in health and
disease. Biochem J. 2011;437(3):357-372.
15. Vernau K, Napoli E, Wong S, et al. Thiamine deciency-mediated
brain mitochondrial pathology in Alaskan Huskies with mutation in
SLC19A3.1. Brain Pathol. 2015;25(4):441-453.
16. Croft L, Napoli E, Hung CK, et al. Clinical evaluation and biochemical
analyses of thiamine deciency in Pacic harbor seals (Phoca vitulina)
maintained at a zoological facility. J Am Vet Med Assoc. 2013;243(8):
17. Leevy CM. Thiamin deciency and alcoholism. Ann N Y Acad Sci.
18. Noble S, Saxena V, Ekker M, Devlin R. Expression of thiaminase
in Zebrash (Danio rerio) is lethal and has implications for use as
a biocontainment strategy in aquaculture and invasive species. Mar
Biotechnol. 2017;19(6):563-569.
19. Nath A, Tran T, Shope TR, Koch TR. Prevalence of clinical thiamine
deciency in individuals with medically complicated obesity. Nutr Res.
20. Tanphaichitr V. Thiamin. In: Shills ME. Olson JA, Shike M, eds.
Modern Nutrition in Health and Disease. 8th ed. Philadelphia, PA: Lea
& Febiger, 1994;359-365.
21. Tanphaichitr V, Wood B. Thiamin. In: Olson RE, Broquist HP,
Chichester CO, et al., eds. Present Knowledge in Nutrition.5thed.
Washington, DC: Nutrition Foundation, 1984;274-284.
22. Crook MA, Sriram K. Thiamine deciency: the importance of recog-
nition and prompt management. Nutrition. 2014;30(7-8):953-954.
23. Sriram K, Manzanares W, Joseph K. Thiamine in nutrition therapy.
Nutr Clin Pract. 2012;27(1):41-50.
24. Koekkoek KWAC, van Zanten ARH. Nutrition in the ICU: new trends
versus old-fashioned standard enteral feeding? Curr Opin Anaesthesiol.
25. Crook MA, Hally V, Panteli JV. The importance of the refeeding
syndrome. Nutrition. 2001;17(2):632-637.
26. Maiorana A, Vergine G, Coletti V, et al. Acute thiamine deciency
and refeeding syndrome: similar ndings but different pathogenesis.
Nutrition. 2014;30(7-8):948-952.
27. Kawamura H, Tanaka S, Uenami Y, et al. Hypophosphatemia occurs
with insulin administration during refeeding by total parenteral nutri-
tion in rats. J Med Invest. 2018;65(1.2):50-55.
Polegato et al 7
28. Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is,
and how to prevent and treat it. BMJ. 2008;336(7659):1495-1498.
29. Collie JTB, Greaves RF, Jones OAH, Lam Q, Eastwood GM, Bellomo
R. Vitamin B1 in critically ill patients: needs and challenges. Clin Chem
Lab Med. 2017;55(11):1652-1668.
30. Mallat J, Lemyze M, Thevenin D. Do not forget to give thiamine to
your septic shock patient!. J Thorac Dis. 2016;8(6):1062-1066.
31. Aasheim ET. Wernicke encephalopathy after bariatric surgery: a sys-
tematic review. Ann Surg. 2008;248(5):714-720.
32. Pellitero S, Mart´
ınez E, Puig R, et al. Evaluation of vitamin and trace
element requirements after sleeve gastrectomy at long term. Obes Surg.
33. Stroh C, Meyer F, Manger T. Beriberi, a severe complication after
metabolic surgery – review of the literature. Obes Facts. 2014;7(4):246-
34. Ijaz S, Thorley H, Porter K, et al. Interventions for preventing
or treating malnutrition in homeless problem-drinkers: a systematic
review. Int J Equity Health. 2018;17(1):8.
35. Fama R, Le Berre A-P, Hardcastle C, et al. Neurological, nutri-
tional and alcohol consumption factors underlie cognitive and mo-
tor decits in chronic alcoholism. Addict Biol. 2017.
10.1111/adb.12584. [Epub ahead of print].
36. Alim U, Bates D, Langevin A, et al. Thiamine prescribing practices
for adult patients admitted to an internal medicine service. Can J Hosp
Pharm. 2017;70(3):179-187.
37. Gerridzen IJ, Hertogh CMPM, Depla MF, Veenhuizen RB, Verschuur
EML, Joling KJ. Neuropsychiatric symptoms in people with Korsakoff
Syndrome and other alcohol-related cognitive disorders living in spe-
cialized long-term care facilities: prevalence, severity, and associated
caregiver distress. J Am Med Dir Assoc. 2018;19(3):240-247.
38. Sanvisens A, Zuluaga P, Fuster D, et al. Long-term mortality of pa-
tients with an alcohol-related Wernicke-Korsakoff syndrome. Alcohol
Alcohol. 2017;52(4):466-471.
39. Cook CC, Hallwood PM, Thomson AD. B Vitamin deciency
and neuropsychiatric syndromes in alcohol misuse. Alcohol Alcohol.
40. Manzanares W, Hardy G. Thiamine supplementation in the critically
ill. Curr Opin Clin Nutr Metab Care. 2011;14(6):610-617.
41. McGarvey C, Franconi C, Prentice D, Bynevelt M. Metformin-
induced encephalopathy:the role of thiamine. Intern Med J. 2018;48(2):
42. Costa NA, Gut AL, Dorna MS, et al. Serum thiamine concentration
and oxidative stress as predictors of mortality in patients with septic
shock. JCritCare. 2014;29(2):249-252.
43. Donnino MW, Andersen LW, Chase M, et al. Randomized, double-
blind, placebo-controlled trial of thiamine as a metabolic resuscitator
in septic shock: a pilot study. Crit Care Med. 2016;44(2):360-367.
44. Andersen LW, Holmberg MJ, Berg KM, et al. Thiamine as an adjunc-
tive therapy in cardiac surgery: a randomized, double-blind, placebo-
controlled, phase II trial. Crit Care. 2016;20:92.
45. Kamas¸ak T, Kul S, Tus¸at M, Ozgun N, Cansu A. A case of Wernicke
Encephalopathy developing after ileal bypass surgery. Pediatr Emerg
Care. 2018;34(12):e223-e225.
46. Lei Y, Zheng MH, Huang W, Zhang J, Lu Y. Wet beriberi with
multiple organ failure remarkably reversed by thiamine administration.
Medicine (Baltimore). 2018;97(9):e0010.
47. Nakamura ZM, Tatreau JR, Rosenstein DL, Park EM. Clinical char-
acteristics and outcomes associated with high-dose intravenous thi-
amine administration in patients with encephalopathy. Psychosomatics.
48. Galvin R, Br ˚
athen G, Ivashynka A, Hillbom M, Tanasescu R,
Leone MA. EFNS guidelines for diagnosis, therapy and prevention of
Wernicke encephalopathy. Eur J Neurol. 2010;17(12):1408-1418.
49. Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-
Korsakoff complex: a retrospective analysis of 131 cases diagnosed at
necropsy. J Neurol Neurosurg Psychiatry. 1986;49(4):341-345.
50. Infante MT, Fancellu R, Murialdo A, Barletta L, Castellan L, Serrati
C. Challenges in diagnosis and treatment of Wernicke Encephalopathy:
Report of 2 cases. Nutr Clin Pract. 2016;31(2):186-190.
51. Arts NJ, Walvoort SJ, Kessels RP. Korsakoff’s syndrome: a critical
review. Neuropsychiatr Dis Treat. 2017;13:2875-2890.
52. Faigle R, Mohme M, Levy M. Dry beriberi mimicking Guillain-
Barre syndrome as the rst presenting sign of thiamine deciency. Eur
JNeurol. 2012;19(2):e14-15.
53. Riahi A, Mansour M, Bedoui I, et al. Acute beriberi neuropathy
mimicking Guillain-Barr´
e syndrome after a strict vegetarian diet. Iran
JNeurol. 2017;16(2):100-102.
54. DiNicolantonio JJ, Niazi AK, Lavie CJ, O’Keefe JH, Ventura HO.
Thiamine supplementation for the treatment of heart failure: a review
of the literature. Congest Heart Fail. 2013;19(4):214-222.
55. DiNicolantonio JJ, Liu J, O’Keefe JH. Thiamine and cardiovascular
disease: a literature review. Prog Cardiovasc Dis. 2018; 61(1):27-32.
56. Roman-Campos D, Cruz JS. Current aspects of thiamine deciency on
heart function. Life Sci. 2014;98(1):1-5.
57. Costa NA, Azevedo PS, Polegato BF, Zornoff LAM, Paiva SAR,
Minicucci MF. Thiamine as a metabolic resuscitator in septic shock:
one size does not t all. J Thorac Dis. 2016;8(6):e471-472.
58. Minicucci MF, Zornoff LAM, Matsue M, et al. Generalized edema
and hyperdynamic circulation: a possible case of beriberi. Arq Bras
Cardiol. 2004;83(2):173-175.
59. Imamura T, KinugawaK. Shoshin beriberi with low cardiac output and
hemodynamic deterioration treated dramatically by thiamine adminis-
tration. Int Heart J. 2015;56(5):568-570.
60. Chisolm-Straker M, Cherkas D. Altered and unstable: wet beriberi, a
clinical review. JEmergMed. 2013;45(3):341-344.
61. Dabar G, Harmouche C, Habr B, Riachi M, Jaber B. Shoshin beriberi
in critically-ill patients: case series. Nutr J. 2015;14:51.
62. Ward KE, Happel KI. An eating disorder leading to wet beriberi heart
failure in a 30-year-old woman. Am J Emerg Med. 2013;31(2):460.e5-
63. Bhat JI, Rather HA, Ahangar AA, et al. Shoshin beriberi-thiamine
responsive pulmonary hypertension in exclusively breastfed infants: a
study from northern India. Indian Heart J. 2017;69(1):24–27.
64. Coelho LS, Hueb JC, Minicucci MF, Azevedo PS, Paiva SAR, Zornoff
LAM. Thiamin deciency as a cause of reversible cor pulmonale. Arq
Bras Cardiol. 2008;91(1):e7-9.
65. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for
the diagnosis and treatment of acute and chronic heart failure: the
Task Force for the diagnosis and treatment of acute and chronic heart
failure of the European Society of Cardiology (ESC). Developed with
the special contribution of the Heart Failure Association (HFA) of the
ESC. Eur Heart J. 2016;37(27):2129-2200.
66. Leite HP, de Lima LFP, de Taddei JAAC, Paes ˆ
AT. Effect of blood
thiamine concentrations on mortality: inuence of nutritional status.
Nutrition. 2018;48:105-110.
67. Soyka M, Kranzler HR, Hesselbrock V, Kasper S, Mutschler J, M¨
HJ. Guidelines for biological treatment of substance use and related
disorders, part 1: alcoholism, rst revision. World J Biol Psychiatry.
68. Giacalone M, Martinelli R, Abramo A, et al. Rapid reversal of severe
lactic acidosis after thiamine administration in critically ill adults: a
report of 3 cases. Nutr Clin Pract. 2015;30(1):104-110.
69. Cottini M, Ranucci M, Facciolo C, et al. An unusual case of cardio-
genic shock in which thiamine administration led to reversal of lactic
acidosis and heart function recovery: Shoshin beriberi in an adolescent.
Int J Cardiol. 2016;222:401-403.
... In the case of WE or WKS, supplementation should be given with 500-1500 mg per day divided into 2 or 3 doses, through intramuscular injection or intravenous route for 5 days. After the initial period, supplementation with an oral dose of 300 mg per day for 1-2 weeks should be given, followed by 100 mg daily for maintenance [54]. For refeeding syndrome, guidelines recommend providing immediately before and during the first 10 days of feeding oral or intravenous thiamine 200-300 mg daily and a balanced multivitamin/trace element supplement once daily [55]. ...
Full-text available
Purpose of Review Alcohol use represents one of the five major causes of morbimortality globally, and alcohol-related liver disease (ALD) is the most common cause of cirrhosis worldwide. Malnutrition is one of the most frequent complications in ALD and is associated with decreased survival. Additionally, protein-energy malnutrition causes sarcopenia, frailty, and immunosuppression. This review summarizes the diverse mechanisms involved in the pathophysiology of malnutrition in ALD and its management. Recent Findings Mechanisms regarding malnutrition in ALD have been recently described. There is also an important area of interest in patients with overnutrition and sarcopenic obesity. Early assessment of malnutrition is needed so the management and prognosis improve in ALD patients. Summary Malnutrition worsens disease progression and increases infections and mortality risk, especially in decompensated patients. It is important to have early recognition and management of this ALD complication. It is also essential to stratify a patient’s risk for refeeding syndrome once the supplementation is given since this syndrome can increase morbimortality.
... YSDZ reversed the downregulation of thiamine induced by CRS. Of note, thiamine is a water-soluble vitamin that plays an important role in the biological processes such as glucose metabolism (Polegato et al., 2019). There is evidence showing that the deficiency of the thiamine led to long-term neurobehavioral deficits, such as anxiety disorders . ...
Full-text available
Anxiety disorder is one of the most common mental diseases. It is mainly characterized by a sudden, recurring but indescribable panic, fear, tension and/or anxiety. Yangshendingzhi granules (YSDZ) are widely used in the treatment of anxiety disorders, but its active ingredients and underlying mechanisms are not yet clear. This study integrates network pharmacology and metabolomics to investigate the potential mechanism of action of YSDZ in a rat model of anxiety. First, potential active ingredients and targets were screened by network pharmacology. Then, predictions were verified by molecular docking, molecular dynamics and western blotting. Metabolomics was used to identify differential metabolites and metabolic pathways. All results were integrated for a comprehensive analysis. Network pharmacology analysis found that Carotene, β-sitosterol, quercetin, Stigmasterol, and kaempferol in YSDZ exert anxiolytic effects mainly by acting on IL1β, GABRA1, PTGS1, ESR1, and TNF targets. Molecular docking results showed that all the affinities were lower than −5 kcal/mol, and the average affinities were −7.7764 kcal/mol. Molecular dynamics simulation results showed that RMSD was lower than 2.5 A, and the overall conformational changes of proteins were small, indicating that the small molecules formed stable complexes with proteins. The results of animal experiments showed that YSDZ exerts anxiolytic effects by regulating GABRA1 and TNF-α, ameliorating pathological damage in hippocampal CA1, and regulating metabolic pathways such as thiamine, cysteine and methionine metabolism, lysine biosynthesis and degradation. Altogether, we reveal multiple mechanisms through which YSDZ exerts its anti-anxiety effects, which may provide a reference for its clinical application and drug development.
... And vegetable blend oil intervention, Thiamine metabolism was increased, while Glycolysis/Gluconeogenesis was decreased. Thiamin is a hydrosoluble vitamin that plays a role in several biological processes, mainly in glucose metabolism 57 . Risk factors for thiamin deficiency include malnutrition, refeeding syndrome, gastrointestinal surgery, and alcohol abuse. ...
Diet is the most direct and rapid contributor to the gut microbiome. Oils and fats are important nutrients in the human body. The effects of lard or vegetable blend oil on gut microbiota were investigated. Kunming mice were given lard or vegetable blend oil for six weeks. Changes in microbiota composition and abundance in lard or vegetable blend oil diets were analyzed by 16S rDNA gene amplicon sequencing. Our study shows that the gut microbiota of mice changed significantly after ingestion of lard or vegetable blend oil. Lard may synergize with Coriobacteriaceae_UCG-002. Vegetable blend oil has synergistic effects with Akkermansia, Roseburia, and Enteractinococcus. Coriobacteriaceae_UCG-002 showed a significant negative correlation with Glycolysis/Gluconeogenesis. Roseburia was most strongly associated with Starch and sucrose metabolism. According to bacterial function prediction and correlation analysis, long-term consumption of lard or vegetable oil may affect glycolipid metabolism, but lard has a greater impact on human health and consequently host health. graphical abstract Fullsize Image
... In Wernicke-Korsakoff syndrome in alcoholic patients, thiamine supplements are typically administered as a dose of 500-1200 mg per day intravenously or via intramuscular injection over 2-3 doses for five days, then an oral dose of 300 mg per day for 1-2 weeks, and finally 100 mg for maintenance. Hence, it is recommended that alcoholic patients should be supplemented with thiamine at a dose of 100-300 mg per day [22]. ...
Full-text available
The importance of B complex vitamins starts early in the human life cycle and continues across its different stages. At the same time, numerous reports have emphasized the critical role of adequate B complex intake. Most studies examined such issues concerning a specific vitamin B or life stage, with the majority reporting the effect of either excess or deficiency. Deep insight into the orchestration of the eight different B vitamins requirements is reviewed across the human life cycle, beginning from fertility and pregnancy and reaching adulthood and senility, emphasizing interactions among them and underlying action mechanisms. The effect of sex is also reviewed for each vitamin at each life stage to highlight the different daily requirements and/or outcomes. Thiamine, riboflavin, niacin, pyridoxine, and folic acid are crucial for maternal and fetal health. During infancy and childhood, B vitamins are integrated with physical and psychological development that have a pivotal impact on one’s overall health in adolescence and adulthood. A higher intake of B vitamins in the elderly is also associated with preventing some aging problems, especially those related to inflammation. All supplementation should be carefully monitored to avoid toxicity and hypervitaminosis. More research should be invested in studying each vitamin individually concerning nutritional disparities in each life stage, with extensive attention paid to cultural differences and lifestyles.
... Thiamine (also called vitamin B1) is a water-soluble vitamin, and its biologically active form is thiamine pyrophosphate in cells, which is an essential coenzyme in the tricarboxylic acid cycle during glucose metabolism and participates in human energy production (Polegato et al., 2019). Thiamine can also maintain the redox state of cells and participate in the antioxidant pathway by producing reduced nicotinamide adenine dinucleotide phosphate (NADPH) and glutathione (Mallat et al., 2016). ...
Full-text available
Background: Ventilator-associated pneumonia (VAP) is a common infection complication in intensive care units (ICU). It not only prolongs mechanical ventilation and ICU and hospital stays, but also increases medical costs and increases the mortality risk of patients. Although many studies have found that thiamine supplementation in critically ill patients may improve prognoses, there is still no research or evidence that thiamine supplementation is beneficial for patients with VAP. The purpose of this study was to determine the association between thiamine and the prognoses of patients with VAP. Methods: This study retrospectively collected all patients with VAP in the ICU from the Medical Information Mart for Intensive Care-IV database. The outcomes were ICU and in-hospital mortality. Patients were divided into the no-thiamine and thiamine groups depending upon whether or not they had received supplementation. Associations between thiamine and the outcomes were tested using Kaplan-Meier (KM) survival curves and Cox proportional-hazards regression models. The statistical methods of propensity-score matching (PSM) and inverse probability weighting (IPW) based on the XGBoost model were also applied to ensure the robustness of our findings. Results: The study finally included 1,654 patients with VAP, comprising 1,151 and 503 in the no-thiamine and thiamine groups, respectively. The KM survival curves indicated that the survival probability differed significantly between the two groups. After multivariate COX regression adjusted for confounding factors, the hazard ratio (95% confidence interval) values for ICU and in-hospital mortality in the thiamine group were 0.57 (0.37, 0.88) and 0.64 (0.45, 0.92), respectively. Moreover, the results of the PSM and IPW analyses were consistent with the original population. Conclusion: Thiamine supplementation may reduce ICU and in-hospital mortality in patients with VAP in the ICU. Thiamine is an inexpensive and safe drug, and so further clinical trials should be conducted to provide more-solid evidence on whether it improves the prognosis of patients with VAP.
Vitamins and their coenzymes roles are indispensable for normal functioning of biochemical metabolic pathways. The water soluble vitamin thiamine plays an important role in energy metabolism and its continuous intake is very essential. The source of vitamins can be obtained from many foods like milk, legumes, peas and rice and which is depends on availability, cost. Although most part of the south Indians especially in Tamilnadu the people predominantly depends on rice as a major source of food. So in order to identify the recommended dietary allowance of thiamine the following rice samples were collected from provisional store in Chennai. The collected five rice samples were Deluxe, Bapatla, Karnataka, Rupali ponni rice and Basmati rice. The concentration of thiamine present in the rice was estimated by UV Spectrophotometrically at 246 nm using 0.1M hydrochloride as blank. In order to measure the actual content the high heat and pressure not used and washing is not used. Among the tested 10gm of rice samples, Rupali ponni rice has127 µg which is very less quantity and Bapatla, Deluxe, Karnataka ponni rice has 420 to 430 µg. The high content of was present in Basmati rice-983 µg. Anyhow normal consuming rice quantity is more sufficient to meet Recommended Daily Allowance- RDA level but more washing of rice, prolong boiling will reduce the amount of thiamine content in rice during usage.
Bariatric surgery is a common and effective treatment modality for morbid obesity worldwide. In the pediatric population, the most commonly performed procedure is the sleeve gastrectomy (SG), and it is considered a restrictive operation, limiting the amount of food a person can tolerate. Its popularity in children lies in its efficacy and low-risk profile. However, side-effects and risks still exist and must be monitored for carefully. Here, we present a case of a 16-year-old female who presented with a chief complaint of paraparesis and confused mental state following a gastric sleeve procedure for obesity a few months prior. MRI of the head demonstrated hyperintensities in dorsomedial parts of her bilateral thalami, mamillary bodies, periaqeductal gray matter, and inferior aspect of the tectal plate, thereby confirming the diagnosis of Wernicke's encephalopathy (WE). There have been only two previous reports of WE following SG in a pediatric patient that have been reported in the literature. We suggest that the mechanism for her thiamine deficiency was secondary to a preexisting subclinical deficiency that became clinically significant secondary to the food restriction imposed by her SG procedure. Pediatric patients who receive a SG procedure should be evaluated for preexisting Thiamine deficiency, started on supplementation at adequate doses and observed for the development of overt deficiency that can potentially result in WE. We recommend using MRI to support the clinical diagnosis due to difficulty in obtaining immediate results from laboratory tests for Vitamin B1 levels. Our review suggests that Hispanic ethnicity and female sex increase the risk of Wernicke's encephalopathy after bariatric surgery.
Full-text available
Sepsis is a clinical syndrome characterized by a severe disorder of pathophysiology caused by infection of pathogenic microorganisms. The addition of antioxidant micronutrient therapies such as thiamine to sepsis treatment remains controversial. This study explored the effect of thiamine on the prognosis of patients with sepsis. This study was a retrospective study involving patients with sepsis from the Medical Information Mart for Intensive Care IV. Patients were divided into two groups, the thiamine received group (TR) and the thiamine unreceived group (TUR), according to whether they were supplemented with thiamin via intravenous while in the intensive care unit (ICU). The primary outcome was ICU mortality. The association between thiamine and outcome was analyzed using the Cox proportional hazard regression model, propensity score matching (PSM), generalized boosted model-based inverse probability of treatment weighting (IPTW), and doubly robust estimation. A total of 11,553 sepsis patients were enrolled in this study. After controlling for potential confounders using Cox regression models, the TR group had a statistically significantly lower ICU mortality risk than the TUR group. The hazard ratio (95% confidence interval) of ICU mortality for the TR group was 0.80 (0.70, 0.93). We obtained the same results after using PSM, IPTW, and doubly robust estimation. Supplementation with thiamine has a beneficial effect on the prognosis of patients with sepsis. More randomized controlled trials are needed to confirm the effectiveness of thiamine supplementation in the treatment of sepsis.
Body is equipped with organic cation transporters (OCTs). These OCTs mediate drug transport and are also involved in some disease process. We aimed to investigate whether liver failure alters intestinal, hepatic and renal Oct expressions using bile duct ligation (BDL) rats. Pharmacokinetic analysis demonstrates that BDL decreases plasma metformin exposure, associated with decreased intestinal absorption and increased urinary excretion. Western blot shows that BDL significantly downregulates intestinal Oct2 and hepatic Oct1 but upregulates renal and hepatic Oct2. In vitro cell experiments show that chenodeoxycholic acid (CDCA), bilirubin and farnesoid X receptor (FXR) agonist GW4064 increase OCT2/Oct2 but decrease OCT1/Oct1, which are remarkably attenuated by glycine-β-muricholic acid and silencing FXR. Significantly lowered intestinal CDCA and increased plasma bilirubin levels contribute to different Octs regulation by BDL, which are confirmed using CDCA-treated and bilirubin-treated rats. A disease-based physiologically based pharmacokinetic model characterizing intestinal, hepatic and renal Octs was successfully developed to predict metformin pharmacokinetics in rats. In conclusion, BDL remarkably downregulates expressions of intestinal Oct2 and hepatic Oct1 protein while upregulates expressions of renal and hepatic Oct2 protein in rats, finally, decreasing plasma exposure and impairing hypoglycemic effects of metformin. BDL differently regulates Oct expressions via Fxr activation by CDCA and bilirubin.
Full-text available
Recent trials have sparked new interest in an old concept – vitamin therapy in critical illness or “metabolic resuscitation”. In this mini-review, we summarize data on the most promising players in this setting: thiamine (vitamin B1), vitamin C and vitamin D.
Full-text available
Purpose of review: The narrative review aims to summarize the relevant studies from the last 2 years and provide contextual information to understand findings. Recent findings: Recent ICU studies have provided insight in the pathophysiology and time course of catabolism, anabolic resistance, and metabolic and endocrine derangements interacting with the provision of calories and proteins.Early provision of high protein intake and caloric overfeeding may confer harm. Refeeding syndrome warrants caloric restriction and to identify patients at risk phosphate monitoring is mandatory.Infectious complications of parenteral nutrition are associated with overfeeding. In recent studies enteral nutrition is no longer superior over parenteral nutrition.Previously reported benefits of glutamine, selenium, and fish oil seem to have vanished in recent studies; however, studies on vitamin C, thiamine, and corticosteroid combinations show promising results. Summary: Studies from the last 2 years will have marked impact on future nutritional support strategies and practice guidelines for critical care nutrition as they challenge several old-fashioned concepts.
Full-text available
Background: Excessive drinking leads to poor absorption of nutrients and homeless problem-drinkers often have nutritionally inadequate diets. Depletion of nutrients such as vitamin B1 can lead to cognitive impairment, which can hinder efforts to reduce drinking or engage with services. This review aimed to assess effectiveness of interventions designed to prevent or treat malnutrition in homeless problem-drinkers. Methods: We systematically searched nine electronic databases and 13 grey literature sources for studies evaluating interventions to improve nutrition in homeless populations, without regional or language restrictions. Screening for inclusion was done in duplicate. One reviewer extracted data and assessed risk of bias, and another checked the extractions. Primary outcomes were nutrition status/deficiency, liver damage, and cognitive function. Secondary outcomes included abstinence, comorbidities, resource use, acceptability and engagement with intervention. Results were synthesised narratively. Results: We included 25 studies (2 Randomised Controlled Trials; 15 uncontrolled before and after; 7 surveys; 1 case-control). Nine studies evaluated educational and support interventions, five food provision, and three supplement provision. Eight studies evaluated a combination of these interventions. No two interventions were the same, and all studies were at high risk of bias. Nutritional status (intake/ deficiency) were reported in 11 studies and liver function in one. Fruit and vegetable intake improved with some education and support interventions (n = 4 studies) but not others (n = 2). Vitamin supplements appeared to improve vitamin deficiency levels in the blood (n = 2). Free or subsidised meals (n = 4) and food packs (n = 1) did not always fulfil dietary needs, but were usually considered acceptable by users. Some multicomponent interventions improved nutrition (n = 3) but acceptability varied (n = 3). No study reported cost effectiveness. Conclusions: The evidence for any one intervention for improving malnutrition in homeless problem-drinkers was based on single studies at high risk of bias. Various food and supplement provision interventions appear effective in changing nutritional status in single studies. Educational and multicomponent interventions show improved nutritional behaviour in some studies but not others. Further better quality evidence is required before these interventions can be recommended for implementation. Any future studies should seek the end user input in their design and conduct. Trial registration: Registered with PROSPERO: CRD42015024247 .
Full-text available
Background Wernicke′s encephalopathy (WE) is a common neuropsychiatric syndrome due to thiamine deficiency. There is no consensus regarding thiamine dosing when WE is suspected. A longstanding dosing strategy for WE is 100 mg daily, yet updated clinical guidelines suggest using high dose intravenous thiamine (HDIV) . Objective To describe thiamine prescribing practices at a large, public academic hospital and investigate clinical characteristics and outcomes associated with HDIV thiamine in patients with encephalopathy who received IV thiamine. Methods Electronic medical records of hospitalized patients who received thiamine between 4/4/2014 and 11/1/2015 were reviewed. Chi-square tests, Wilcoxon Rank Sum tests, and logistic regression were used to compare clinical variables in patients with encephalopathy who received HDIV thiamine (≥ 200 mg twice daily) vs. lower doses of IV thiamine. Results Among the total 5,236 thiamine orders, 29% (n=1,531) were IV; 10% (n=150) of IV orders met HDIV criteria. In patients with encephalopathy who received IV thiamine (n=432), HDIV thiamine was administered to 20% (n=86) and only 2.1% (n=9) received dosing consistent with Royal College of Physicians guidelines. In bivariable analyses, HDIV thiamine was associated with surgical services (p=0.001), psychiatric consultation (p<0.001), and decreased mortality (p=0.004). In multivariable models, the association between HDIV thiamine and decreased in-hospital mortality did not meet statistical significance (p=0.061). Conclusions In a large, public academic hospital, guideline-concordant thiamine supplementation is rare and HDIV thiamine is infrequently prescribed to patients with encephalopathy. Further studies are needed to confirm the possible benefits of HDIV thiamine for patients with suspected thiamine-deficient encephalopathy.
Wernicke encephalopathy is an acute neurological problem resulting from thiamine deficiency and manifesting with mental confusion, oculomotor dysfunction, and ataxia. It is associated with alcohol dependence in adults. Preparatory factors include hyperemesis gravidarum, prolonged diarrhea, prolonged parental nutrition without vitamin support, absorption disorders, anorexia, cancer, and chemotherapy. Failure to consider the clinical findings and preparatory factors of this disease, which is rare in children, can delay diagnosis. This report describes a case of Wernicke encephalopathy developing in a patient with brid ileus and receiving total parenteral nutrition after partial ileal bypass surgery. The patient's clinical and cranial magnetic resonance findings were compatible with Wernicke encephalopathy. Although these are not widespread, typical ocular findings for Wernicke encephalopathy were present. Dramatic improvements were observed in clinical, ocular, and cranial magnetic resonance findings after treatment.
Refeeding syndrome (RFS) is characterized by the metabolic and clinical changes that occur following aggressive nutritional supplementation in malnourished patients. Hypophosphatemia is the hallmark of RFS and is key to its prevention and treatment in clinical practice. However, the mechanism of hypophosphatemia during RFS is unclear because of the lack of an animal model. In this study, we developed a rat RFS model as a first step to clarifying the molecular mechanism. After establishing the parenteral route, rats were fasted for 5 days and refeeding was started using total parenteral nutrition. The animals were infused with a high calorie solution with or without insulin administration. Results showed that plasma phosphate levels did not decrease in rats infused with the high calorie solution alone;in contrast, a 20% reduction compared to baseline was observed in rats administered insulin. In addition, rats infused with the high calorie solution containing added phosphate did not present with hypophosphatemia. Thus, we developed a rat RFS model with hypophosphatemia by tube feeding and insulin administration, and demonstrated the importance of phosphate in preventing refeeding hypophosphatemia. J. Med. Invest. 65:50-55, February, 2018.
A case of metformin encephalopathy is presented in a patient on haemodialysis for end-stage diabetic renal failure. The patient presented with frequent falls and clinical signs of Parkinsonism, on a background of recent anorexia and significant weight loss. Magnetic resonance imaging showed bilateral, symmetrical abnormalities centred on the lentiform nuclei. Metformin was withheld and signs and symptoms quickly resolved. We hypothesise that metformin may cause thiamine deficiency in patients with end-stage renal failure resulting in a specific metabolic encephalopathy.
Thiamine is a water-soluble vitamin that plays an important role in the energy metabolism in the human body. Deficiency in thiamine can lead to neurological abnormalities and congestive heart failure (HF), known as dry beriberi and wet beriberi respectively. Several populations are at higher risk for thiamine deficiency, most notably persons with chronic alcoholism. This article aims to provide a review of current literature on the role of thiamine in the human body, the current scope of thiamine deficiency, and explore the specific effects of thiamine deficiency and supplementation on the cardiovascular system. HF as a result of thiamine deficiency can have non-specific presentations, often leading to delayed diagnosis and treatment. Having an understanding of pathophysiology of thiamine deficiency and considering thiamine deficiency as one of the differentials in patients with new onset HF of unknown etiology with the appropriate risk factors is important in clinical practice.
Variations in pattern and extent of cognitive and motor impairment occur in alcoholism (ALC). Causes of such heterogeneity are elusive and inconsistently accounted for by demographic or alcohol consumption differences. We examined neurological and nutritional factors as possible contributors to heterogeneity in impairment. Participants with ALC (n = 96) and a normal comparison group (n = 41) were examined on six cognitive and motor domains. Signs of historically determined subclinical Wernicke's encephalopathy were detected using the Caine et al. criteria, which were based on postmortem examination and chart review of antemortem data of alcoholic cases with postmortem evidence for Wernicke's encephalopathy. Herein, four Caine criteria provided quantification of dietary deficiency, cerebellar dysfunction, low general cognitive functioning and oculomotor abnormalities in 86 of the 96 ALC participants. Subgroups based on Caine criteria yielded a graded effect, where those meeting more criteria exhibited greater impairment than those meeting no to fewer criteria. These results could not be accounted for by history of drug dependence. Multiple regression indicated that compromised performance on ataxia, indicative of cerebellar dysfunction, predicted non-mnemonic and upper motor deficits, whereas low whole blood thiamine level, consistent with limbic circuit dysfunction, predicted mnemonic deficits. This double dissociation indicates biological markers that contribute to heterogeneity in expression of functional impairment in ALC. That non-mnemonic and mnemonic deficits are subserved by the dissociable neural systems of frontocerebellar and limbic circuitry, both commonly disrupted in ALC, suggests neural mechanisms that can differentially affect selective functions, thereby contributing to heterogeneity in pattern and extent of dysfunction in ALC.
Objective: To test the hypothesis that low blood thiamine concentrations in malnourished critically ill children are associated with higher risk of 30-d mortality. Methods: Prospective cohort study in 202 consecutively admitted children who had whole blood thiamine concentrations assessed on admission and on days 5 and 10 of intensive care unit (ICU) stay. The primary outcome variable was 30-d mortality. Mean blood thiamine concentrations within the first 10 d of ICU stay, age, sex, malnutrition, C-reactive protein concentration, Pediatric Index of Mortality 2 score, and severe sepsis/septic shock were the main potential exposure variables for outcome. Results: Thiamine deficiency was detected in 61 patients within the first 10 d of ICU stay, 57 cases being diagnosed on admission and 4 new cases on the 5th d. C-reactive protein concentration during ICU stay was independently associated with decreased blood thiamine concentrations (P = 0.003). There was a significant statistical interaction between mean blood thiamine concentrations and malnutrition on the risk of 30-d mortality (P = 0.002). In an adjusted analysis, mean blood thiamine concentrations were associated with a decrease in the mortality risk in malnourished patients (odds ratio = 0.85; 95% confidence interval [CI]: 0.73-0.98; P = 0.029), whereas no effect was noted for well-nourished patients (odds ratio: 1.03; 95% CI: 0.94-1.13; P = 0.46). Conclusions: Blood thiamine concentration probably has a protective effect on the risk of 30-d mortality in malnourished patients but not in those who were well nourished.